L’Oréal and Verily announce strategic partnership to advance precision skin health

L’Oréal has launched a strategic partnership with precision health research organisation Verily to advance skin health.

The partnership aims to understand and characterise skin and hair ageing mechanisms to develop L’Oréal’s precision beauty tech strategy and product development.

The strategic research collaboration aims to establish a biological, clinical and environmental view of skin health. It will combine L’Oréal’s scientific knowledge of skin and Verily’s clinical science capabilities, to decode the links between exposome, skin ageing and deep biology of the skin.

Verily and L’Oréal’s Active Cosmetics Division will then explore the development of new technologies and tele-diagnosis solutions, such as AI algorithms for dermatology and skincare, to form a basis for new services.

Nicolas Hieronimus, CEO at L’Oréal Group, said: “We are excited to partner with Verily, a world leader in precision health technology. L’Oréal’s century-long commitment to pioneering innovation has come from our strong belief in the intersection between science, formulations and our unique advanced research capabilities to decode revolutionary scientific discoveries that will create the future of beauty.

“Thanks to this partnership, we want to lead a new era of skin health, through tech and science, to enable every person around the world the most inclusive, personalised, powerful and precise programs for their skin at each stage of their lives.”

Stephen Gillett, President and COO at Verily, said: “Verily and L’Oréal believe in the transformative power of technology to enable precision beauty and health. We are pleased to partner with a world leader in cosmetic science to better understand and promote skin health.”